TP53 and esophageal adenocarcinoma: Likewise, genomic analyses tracking the evolution of esophageal adenocarcinoma from its precursor lesion, Barrett’s esophagus, have confirmed that TP53 mutation or loss of heterozygosity is the most significant driver of progression to invasive cancer [168].